Velimir A. Luketic

25.0k total citations · 6 hit papers
176 papers, 14.2k citations indexed

About

Velimir A. Luketic is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Velimir A. Luketic has authored 176 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Hepatology, 130 papers in Epidemiology and 50 papers in Surgery. Recurrent topics in Velimir A. Luketic's work include Liver Disease Diagnosis and Treatment (114 papers), Liver Disease and Transplantation (72 papers) and Hepatitis C virus research (49 papers). Velimir A. Luketic is often cited by papers focused on Liver Disease Diagnosis and Treatment (114 papers), Liver Disease and Transplantation (72 papers) and Hepatitis C virus research (49 papers). Velimir A. Luketic collaborates with scholars based in United States, United Kingdom and Canada. Velimir A. Luketic's co-authors include Arun J. Sanyal, Richard K. Sterling, Mitchell L. Shiffman, Melissa J. Contos, Robert A. Fisher, Faridoddin Mirshahi, John N. Clore, Carol Sargeant, Prem Puri and A. Scott Mills and has published in prestigious journals such as The Journal of Experimental Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Velimir A. Luketic

173 papers receiving 13.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

2001 1.7k citations Arun J. Sanyal, Faridoddin Mirshahi et al. Gastroenterology profile →
Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values

2003 909 citations Melissa J. Contos, Carol Sargeant et al. Hepatology profile →
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

2008 557 citations Prem Puri, Melissa J. Contos et al. Hepatology profile →
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #

2009 478 citations Kris V. Kowdley, Velimir A. Luketic et al. Hepatology profile →
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

2014 421 citations Gideon M. Hirschfield, Andrew L. Mason et al. Gastroenterology profile →
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

2017 325 citations Prem Puri, Kalyani Daita et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Velimir A. Luketic United States	58	10.5k	9.1k	4.7k	2.3k	1.5k	176	14.2k
Richard K. Sterling United States	66	15.8k 1.5×	13.7k 1.5×	4.4k 0.9×	2.9k 1.3×	2.1k 1.4×	326	20.6k
Flemming Bendtsen Denmark	53	8.0k 0.8×	6.5k 0.7×	4.1k 0.9×	1.3k 0.6×	1.2k 0.8×	340	12.1k
Emmanuel Tsochatzis United Kingdom	55	12.1k 1.2×	9.4k 1.0×	3.4k 0.7×	2.5k 1.1×	1.4k 0.9×	308	15.8k
George N. Ioannou United States	59	8.0k 0.8×	5.6k 0.6×	2.1k 0.5×	1.7k 0.7×	2.0k 1.3×	211	12.6k
Aijaz Ahmed United States	53	7.8k 0.7×	5.5k 0.6×	1.8k 0.4×	2.1k 0.9×	948 0.6×	322	10.7k
Hendrik Vilstrup Denmark	53	6.4k 0.6×	5.8k 0.6×	3.2k 0.7×	1.3k 0.6×	1.0k 0.7×	260	10.5k
Juan Rodés Spain	65	13.9k 1.3×	16.6k 1.8×	7.0k 1.5×	547 0.2×	1.2k 0.8×	188	20.0k
Han‐Chieh Lin Taiwan	53	6.6k 0.6×	7.6k 0.8×	3.7k 0.8×	576 0.3×	842 0.6×	456	11.7k
Philippe Mathurin France	66	14.1k 1.3×	9.7k 1.1×	2.7k 0.6×	3.1k 1.4×	1.9k 1.3×	349	19.0k
Amedeo Lonardo Italy	61	11.3k 1.1×	4.3k 0.5×	2.0k 0.4×	5.9k 2.6×	1.7k 1.1×	202	14.4k

Countries citing papers authored by Velimir A. Luketic

Since Specialization

Citations

This map shows the geographic impact of Velimir A. Luketic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Velimir A. Luketic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Velimir A. Luketic more than expected).

Fields of papers citing papers by Velimir A. Luketic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Velimir A. Luketic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Velimir A. Luketic. The network helps show where Velimir A. Luketic may publish in the future.

Co-authorship network of co-authors of Velimir A. Luketic

This figure shows the co-authorship network connecting the top 25 collaborators of Velimir A. Luketic. A scholar is included among the top collaborators of Velimir A. Luketic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Velimir A. Luketic. Velimir A. Luketic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fagan, Andrew, Edith Gavis, Brian Davis, et al.. (2022). A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study. Journal of Hepatology. 78(2). 312–321. 39 indexed citations

Schattenberg, Jörn M., Albert Parés, Kris V. Kowdley, et al.. (2021). A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. Journal of Hepatology. 74(6). 1344–1354. 125 indexed citations

Patel, Samarth, Mohammad Siddiqui, Mohammad Siddiqui, et al.. (2020). Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 19(10). 2202–2204. 16 indexed citations

Sterling, Richard K., Carolyn Driscoll, Scott Matherly, et al.. (2018). Treatment of HCV in the Department of Corrections in the Era of Oral Medications. Journal of Correctional Health Care. 24(2). 127–136. 30 indexed citations

Puri, Prem, Kalyani Daita, Andrew Joyce, et al.. (2017). The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology. 67(2). 534–548. 325 indexed citations breakdown →

Gane, Edward, Ronald Nahass, Velimir A. Luketic, et al.. (2015). P0776 : Efficacy of 12 or 18 weeks of grazoprevir plus elbasvir with ribavirin in treatment-naive, noncirrhotic HCV genotype 3-infected patients. Journal of Hepatology. 62. S621–S621. 9 indexed citations

Siddiqui, Mohammad Shadab, Michael Fuchs, Michael O. Idowu, et al.. (2014). Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile. Clinical Gastroenterology and Hepatology. 13(5). 1000–1008.e3. 174 indexed citations

Kowdley, Kris V., Velimir A. Luketic, Robert Chapman, et al.. (2011). 28 AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID AS MONOTHERAPY IN PBC. Journal of Hepatology. 54. S13–S13. 47 indexed citations

Stravitz, R. Todd, Ton Lisman, Velimir A. Luketic, et al.. (2010). ACUTE LIVER INJURY/FAILURE (ALI/ALF) RESULTS IN BALANCED HEMOSTASIS DESPITE ELEVATED INR. Hepatology. 52(4). 1 indexed citations

10.

Yılmaz, Nevin, Mitchell L. Shiffman, R. Todd Stravitz, et al.. (2007). Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years. Liver International. 28(1). 72–78. 17 indexed citations

11.

Peters, Marion G., Adrian M. Di Bisceglie, Kris V. Kowdley, et al.. (2007). Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology. 46(3). 769–775. 50 indexed citations

12.

Shiffman, Mitchell L., Angie Price, Richard K. Sterling, et al.. (2007). Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha†. Hepatology. 46(2). 371–379. 144 indexed citations

13.

Dickson, Rolland C., Norah A. Terrault, Michael B. Ishitani, et al.. (2005). Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transplantation. 12(1). 124–133. 33 indexed citations

14.

Combes, Burton, Velimir A. Luketic, Marion G. Peters, et al.. (2004). Prolonged Follow-Up of Patients in the U.S. Multicenter Trial of Ursodeoxycholic Acid for Primary Biliary Cirrhosis. The American Journal of Gastroenterology. 99(2). 264–268. 30 indexed citations

15.

Sterling, Richard K., Velimir A. Luketic, Arun J. Sanyal, et al.. (2003). 100 A prospective, randomized controlled pilot study of ursodeoxycholic acid (UDCA) combined with mycophenolate mofetil (MMF) in the treatment of primary sclerosing cholangitis. Hepatology. 38. 204–204. 1 indexed citations

16.

Keeffe, Emmet B., Robert P. Perrillo, Albert D. Min, et al.. (2003). Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology. 125(2). 444–451. 232 indexed citations

17.

Kita, Hiroto, Zhe‐Xiong Lian, Judy Van de Water, et al.. (2002). Identification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis. The Journal of Experimental Medicine. 195(1). 113–123. 229 indexed citations

18.

Contos, Melissa J., Richard K. Sterling, Velimir A. Luketic, et al.. (2001). Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transplantation. 7(4). 363–373. 290 indexed citations

19.

Marcos, Amadeo, Robert A. Fisher, J. M. Ham, et al.. (1999). RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION. Transplantation. 68(6). 798–803. 340 indexed citations

20.

Shiffman, Mitchell L., Charlotte M. Hofmann, Velimir A. Luketic, & Arun J. Sanyal. (1998). Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C. Journal of Hepatology. 28(3). 382–389. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact